| Budget Amount *help |
¥19,110,000 (Direct Cost: ¥14,700,000、Indirect Cost: ¥4,410,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2016: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2015: ¥12,610,000 (Direct Cost: ¥9,700,000、Indirect Cost: ¥2,910,000)
|
|---|
| Outline of Final Research Achievements |
This study aims to develop genome editing technology of next generation for human functional genomics by improving CRISPR method. The CRISPR system is a new genome editing technology based on a prokaryotic acquired immune system, and has attracted attention as a breakthrough technology applicable to all kinds of organisms. In the CRISPR system, a guide RNA that distinguishes a target genomic site with a complementary base sequence forms a complex with a Cas9 protein, and Cas9 cleaves a genomic region where the guide RNA forms base-pairing. Therefore, in this study, using dCas9 which has no genome cleavage activity, we succeeded in establishing a practical CRISPR technique with high genome editing efficiency by combining experimental method and bioinformatics method.
|
